NASDAQ · Medical - Devices
QTI (QTI) Stock
$2.74
+0.37%
NASDAQ: QTI
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
QT Imaging Completes First Routine FDA Inspection With Zero Form 483 Observations
MT Newswires · Jul 7, 2026
QT Imaging Announces Successful Completion of First FDA Routine Inspection with Zero Form 483 Observations
Business Wire · Jul 7, 2026
QT Imaging’s CEO Presents Sports Shiftmaker Award to Tennis Champion and Breast Cancer Survivor Martina Navratilova During Wimbledon Week
Business Wire · Jun 29, 2026
A New Standard of Reproducibility for Quantitative Biomarkers in Breast Imaging
Business Wire · Jun 24, 2026
Spotlight On June 2026's Insider-Favored Growth Stocks
Simply Wall St. · Jun 12, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held25.07%
Institutions Held17.09%
Institutions Float Held22.81%
Peer Comparison
About QTI
QTI is led by CEO Raluca Dinu, publicly traded since 2024.
QTI stock trades at $2.74 with a market capitalization of $74.35M. The stock is valued at a price-to-earnings (P/E) ratio of -2.52, price-to-book of 22.88, price-to-sales of 6.06. Over the past 52 weeks the stock has ranged between $2.71 and $46.05, and currently trades 94.0% below its 52-week high.
On profitability, QTI generates a return on equity (ROE) of -350.00%, return on capital employed of -66.67%, an operating margin of -21.05%, a net profit margin of -58.94%.